Rafael Holdings Inc. Class B

Rafael Holdings Inc. Class B is not very popular among insiders. Tradey thinks it is not wise to invest in Rafael Holdings Inc. Class B.
Log in to see more information.
Rafael Holdings, Inc. owns commercial real estate assets and interests in clinical and early stage p...
RFL Fundamental Data by TradingView

News

CYCLO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cyclo Therapeutics, Inc. - CYTH
CYCLO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cyclo Therapeutics, Inc. - CYTH

Business Wire Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed merger of Cyclo Therapeutics, Inc. (the Company...\n more…

RFL Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Rafael Holdings, Inc. Is Fair to Shareholders
RFL Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Rafael Holdings, Inc. Is Fair to Shareholders

Business Wire Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Rafael Holdings, Inc. (NYSE: RFL) and Cyclo Therapeutics, Inc. is fair to Rafael shareholders. Halper Sadeh...\n more…

Cyclo Therapeutics falls after merger agreement with Rafael Holdings
Cyclo Therapeutics falls after merger agreement with Rafael Holdings

Seeking Alpha - Healthcare Cyclo Therapeutics falls after merger agreement with Rafael Holdings...\n more…

Rafael Holdings, Cyclo Therapeutics enter merger agreement
Rafael Holdings, Cyclo Therapeutics enter merger agreement

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Rafael Holdings and Cyclo Therapeutics Enter into a Definitive Merger Agreement
Rafael Holdings and Cyclo Therapeutics Enter into a Definitive Merger Agreement

Business Wire Rafael Holdings, Inc. (NYSE: RFL), and Cyclo Therapeutics, Inc. (Nasdaq: CYTH) today announced that they have entered into a definitive merger agreement to combine the two companies to focus on the...\n more…

Rafael Holdings Third Quarter 2024 Earnings: US$1.36 loss per share (vs US$0.061 loss in 3Q 2023)
Rafael Holdings Third Quarter 2024 Earnings: US$1.36 loss per share (vs US$0.061 loss in 3Q 2023)

Simply Wall St Rafael Holdings ( NYSE:RFL ) Third Quarter 2024 Results Key Financial Results Net loss: US$32.4m (loss widened by...\n more…